Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 14, 2019 / 06:20PM GMT
Release Date Price: $131.67 (+0.40%)
Juan Esteban Avendano
BofA Merrill Lynch, Research Division - Associate

We'll go ahead and get started. Good morning. Welcome to the 2019 Bank of America Health Care Conference. Once again, my name is Juan Avendano, and I am an analyst in the life sciences tools and diagnostics team, which is led by Derik De Bruin. I focus on coverage of CROs and CDMOs, and I'm pleased to be joined on stage by Charles River. With us, we have David Smith, their CFO; and Birgit Girshick, who runs the Discovery and Safety Assessment segment as well as the Biologics Testing Solutions business. Welcome, and thank you once again for participating.

Questions & Answers

Juan Esteban Avendano
BofA Merrill Lynch, Research Division - Associate

I guess, David, if you could start us off by summarizing the first quarter results that you just reported last week, that would be great. Thank you.

David Ross Smith
Charles River Laboratories International, Inc. - Corporate Executive VP & CFO

Okay. So in Q1, well, we're pleased with Q1,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot